From the Journals

Metformin and AMD: Signal or Noise?

Five-year population study details 37% lower incidence of intermediate AMD in type 2 diabetic patients prescribed metformin

Share

  • 1

    - Metformin linked to a 37% lower incidence of intermediate AMD. - Study conducted in Liverpool under ISDR program. - Used systematic retinal image grading for accuracy. - No significant reduction in early AMD or late progression. - Findings emphasize potential benefits for metformin beyond glycemic control. - Observational study, causality not established. - Calls for further clinical trials on metformin for AMD reduction.

Original Source(s)

Metformin and AMD: Signal or Noise?

Five-year population study details 37% lower incidence of intermediate AMD in type 2 diabetic patients prescribed metformin

  • by Conexiant News Staff

  • February 16, 2026

  • 4 min

Related Content

Coding Q&A: Coding Guidelines for Wet AMD

Proper use of ICD-10-CM codes ensures compliance and prompt payment.

A Solution for Irregular Astigmatism Pre-Cataract Surgery

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

  • November 1, 2020

  • 8 min
Integration of Vision Services Remains an Unmet Need in FQHCs

Telemedicine, funding, and provider partnerships can help, researchers say.